Meta AnalysisID 7788
硫酸镁治疗慢性阻塞性肺疾病急性加重有效性和安全性的Meta分析
CRD42023484670
The efficacy and safety of intravenous magnesium sulfate in patients with acute exacerbation of chronic obstructive pulmonary disease.
Relationship Network
Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.
Click a node to open it in a new tab
Ingredient: 1Meta-analysis: 1Links: 1
Arranging relationship network...
Record Fields
Scalar fields from the final meta_analysis record.
- Meta Analysis Id
- 7788
- Evidence Id
- 16346
- Core Evidence Id
- 16346
- Source Meta Analysis Id
- 7786
- Herb2 Meta Analysis Id
- HBMA007786
- Crd Id
- CRD42023484670
- Title
- A meta-analysis of the effectiveness and safety of magnesium sulfate in the treatment of AECOPD
- Review Question
- The efficacy and safety of intravenous magnesium sulfate in patients with acute exacerbation of chronic obstructive pulmonary disease.
- Study Type Included
- Articles analyzing the effectiveness of magnesium sulfate in treating acute exacerbations of COPD were included. Study patients were diagnosed according to guidelines for the diagnosis and treatment of chronic obstructive pulmonary disease. The outcomes included clinical efficacy, lung function, arterial blood gases, and adverse effects. The exclusion criteria were as following: (1) non-human studies; (2) non-comparative studies; (3) Studies of multiple interventions; (4) non-original studies (letters, reviews, editorials).
- Condition Being Studied
- Chronic obstructive pulmonary disease (COPD) is a chronic and progressive disease, often punctuated by recurrent flare-ups or exacerbations. Magnesium sulfate, having a bronchodilatory effect, may have a potential role as an adjunct treatment in COPD exacerbations. However, comprehensive evidence of its effects is required to facilitate clinical decision-making.
- Participant
- Articles analyzing the effectiveness of magnesium sulfate in treating acute exacerbations of COPD were included. Study patients were diagnosed according to guidelines for the diagnosis and treatment of chronic obstructive pulmonary disease. The outcomes included clinical efficacy, lung function, arterial blood gases, and adverse effects. The exclusion criteria were as following: (1) non-human studies; (2) non-comparative studies; (3) Studies of multiple interventions; (4) non-original studies (letters, reviews, editorials).
- Animal
- Human Disease Modelled
- Intervention
- Intravenous magnesium sulfate
- Comparator Control
- placebo
- Main Outcome
- Clinical efficacy, lung function, PEFR
- Outcome Measure
- Additional Outcome
- Arterial blood gas, DSS, RR, adverse reactions
- Study Method
- Meta-analysis, Systematic review
- Keyword
- MeSH headings have not been applied to this record
- Contact
- Hui Li [email protected]
- Organisational Affiliation
- Department of General Medicine, The First Affiliated Hospital of Xinjiang Medical University
- Funding Source
- Other Selection Criteria
- Final Publication
- Same Topic Review
- Published Protocol
- Review Type
- Language
- English
- Country
- China
- Review Stage
- Review Ongoing
- First Submission Date
- 2023-11-19
- Registration Date
- 2023-11-30
- Anticipated Start Date
- 2023-05-01
- Anticipated Completion Date
- 2023-12-26
- Title Cn
- 硫酸镁治疗慢性阻塞性肺疾病急性加重有效性和安全性的Meta分析
- Title En
- A meta-analysis of the effectiveness and safety of magnesium sulfate in the treatment of AECOPD
- Bilingual Status
- complete